The most common immune-mediated disorders in two phase 3 clinical trials of the vaccine were psoriasis, spondyloarthropathy, rheumatoid arthritis...
No increase was seen in hospitalization and death rates, providing additional support for keeping patients on these immunosuppressive treatments...
This test is not endorsed by the American Academy of Dermatology or National Comprehensive Cancer Network outside of studies.
Approval was based in part on a pair of phase 3, double-blind, vehicle-controlled, 12-week, randomized trials.
Patients should continue taking the antihypertensive drug unless their doctor says otherwise, according to an FDA...
These skin signs could augment coagulation assays in this patient population.
The latest updated psoriasis treatment guidelines address topicals, alternative medicine, and severity assessment.
It is not a stretch to suggest that skin manifestations associated with COVID-19 may look very different in darker skin.
Histopathologic exams were done for only 23 patients and, in all cases, showed “inflammatory features without specific pathological changes.”